Oral Delivery of the Vancomycin Derivative FU002 by a Surface-Modified Liposomal Nanocarrier.
Werner J, Umstätter F, Hertlein T, Mühlberg E, Beijer B, Wohlfart S, Zimmermann S, Haberkorn U, Ohlsen K, Fricker G, Mier W, Uhl P.
Werner J, et al. Among authors: hertlein t.
Adv Healthc Mater. 2024 Feb 22:e2303654. doi: 10.1002/adhm.202303654. Online ahead of print.
Adv Healthc Mater. 2024.
PMID: 38387090